drugset / Trial / NCT04964414

Treatment of Pediatric Patients That Lost Sense of Smell Due to COVID-19

NCT04964414

Phase 1/2 Terminated 20 enrolled Amanda Stapleton
RandomizedParallel-groupOpen-labelTreatment

Summary

This research study is a randomized controlled trial in pediatric and young adult patients who have lost their sense of smell due to COVID-19 viral infection. The goals are: 1. to learn more about the effects of smell retraining therapy on smell loss following COVID-19 and 2. to determine if budesonide-saline irrigations make smell retraining therapy more effective.

Timeline

Start
2021-09-30
Primary completion
2023-01-13
Completion
2023-03-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule 0.5 mg Other